|
|
 |
 |
|
|
|
|
|
|
 |
 |
 |
 |
|
|
|
|
 |
|
In association with: CEnter For Anti-Infective Agents (CEFAIA)
Optimising development in the anti-infectives market
25th April 2007, Crowne Plaza Hotel - The City, London.
|
|
|
This Executive Briefing will explore the biggest issues in antibacterial resistance looking in-depth at the current market and forward 10 years into the future. Attendees will explore the resistance problem and examine the current R&D pipeline.
|
|
|
 |
Ursula Theuretzbacher, Founder, Center For Anti-Infective Agents.
About Your Briefing Leader: Ursula Theuretzbacher, Ph.D, Founder, CEnter For Anti-Infective Agents (CEFAIA) Dr. Theuretzbacher’s work to generate research portfolios, discover and assess licensing opportunities, and develop optimal R&D strategies in the anti-infective field has been critical to the business success of numerous start-up and established companies. An internationally sought after speaker and author, her highly regarded textbooks, scientific articles, and reviews are significant additions to the anti-infective frontier. Formerly a lecturer at the University of Vienna, she is a board member of several international scientific societies.
CEnter For Anti-Infective Agents (CEFAIA) The Center for Anti-Infective Agents (CEFAIA) is a private independent consulting institute. It was founded in 1988 by Ursula Theuretzbacher who offers an integrated approach based on scientific expertise, knowledge of the anti-infective market, and international presence. CEFAIA assists companies worldwide with; - Developing R&D strategies including product profile development, clinical trial evaluation and development strategy
- Business development including licensing evaluation support, product and technology analysis and opportunity assessment, identifying suitable products and partners as well as acting as transatlantic liaison
- Knowledge management including generating, collecting, interpreting and communicating scientific, medical and business information, using in-house and external databases, scientific and business publications
- Expert advice including topics about resistance, pharmacokinetic and pharmakodynamic issues, the future of antimicrobials (new targets), adequate use of antibiotics and antifungals.
|
 |
|
|
|
|
|
 |
|
Would your organisation be interested in running an Executive Briefing at a future SMi event?
Executive Briefings are interactive one- or half-day sessions which are attached to a specific conference and are run, on average with between 5 and 10 delegates, to explore a highly-focussed and niche aspect of the overall topic. Running an SMi workshop guarantees you one-to-one access with executives who have actively expressed a keen interest in the subject matter, giving you an excellent opportunity to promote your organisation to your target market.
In addition, your company logo and promotional information appears on all SMi marketing brochures and web site. If you are interested in running an executive briefing or speaking at a conference, please contact SMi on +44 (0) 870 9090 711; client_services@smi-online.co.uk
|
|
|
 |
 |
 |
 |
|
 |
|
 |